MY ACCOUNT | NEWSLETTER |

A European project proposes to reduce the use of antibiotics in poultry farming with alternative therapies against multi-resistant bacteria


The control of multiresistant bacteria to antibiotics is one of the main global health challenges. In the face of the so-called "silent pandemic," it is necessary to design alternative strategies to combat bacterial infections, both in animals and in humans, whose treatment is no longer effective with known antibiotics. In the case of food-producing animals, controlling the proliferation of multiresistant bacteria, in turn, reduces the risk of their transmission to humans and the environment.

With this One Health approach, CEU UCH researchers participate in the international project "Phage-Stop-AMR," which proposes the design of bacteriophage therapies as an alternative to the use of antibiotics to reduce the proliferation of Salmonella and E. coli, both multiresistant, in chickens from poultry farms.

As the project researchers explain, bacteriophage therapies can help reduce the use of antibiotics in animal production to combat bacteria that have acquired multi-resistance to these drugs. "Bacteriophages are viruses that specifically attack certain bacteria, so their use against those that have multiple resistance to antibiotics is considered an alternative antimicrobial strategy, beneficial for animal and human health, as well as respectful with the environment."

In the "Phage-Stop-AMR" project, researchers from five countries will work with two of the bacteria declared to be of greatest importance in public and animal health and that present high multi-resistance to antibiotics: Salmonella and E. coli. The most effective combination of bacteriophages for the reduction of these bacteria and their resistance genes in broilers will be studied. In the study, the impact of phage therapy on the intestinal parameters of the treated animals will be verified, carrying out the analysis of these birds' intestinal microbiome and resistome. And an early warning system for multiresistant food pathogens in farms will also be developed to facilitate their detection in situ and prevent their transmission from farm to table.

International project "Phage-Stop-AMR"

"Phage-Stop-AMR" is one of the projects in the "One Health interventions to prevent or reduce the development and transmission of AMR" area of ​​the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). Headquartered at the Swedish Research Council in Stockholm, this international platform is made up of the EU and 29 countries and promotes the One Health approach, which combines the perspectives of human, animal and environmental health, as a strategy to stop the increase in resistance bacteria to antibiotics, whose effectiveness has been reduced due to the abuse or misuse of these drugs in recent decades.

Together with the CEU UCH, seven researchers from the University of Münster, in Germany, are partners of the "Phage-Stop-AMR" project; Loughborough University and the Animal and Plant Health Agency, from the United Kingdom; Tel Aviv University, in Israel; the Veterinary Medical Research Institute of Hungary; and the University of Cantabria.

The subproject carried out in Valencia is coordinated by doctors Clara Marín and Santiago Vega, from CEU Cardenal Herrera University, experts in the control of these pathogens from a One Health point of view. In addition, it has the participation of researchers of Francisco Marco Jiménez, from the Polytechnic University of Valencia (UPV) for the application of omic sciences, and Pablo Catalá and Sandra Sevilla, from the Center for Poultry Quality and Animal Feed of the Valencian Community. , thus counting on the support of the Valencian poultry sector for this alternative therapeutic strategy to the use of antibiotics.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top